What are the molecular consequences of germline mutations in breast and ovarian cancer susceptibility genes in a Norwegian breast and ovarian cancer population

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  2018-06-01

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Fanconi Anemia

  2019cited by this paper
• The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

  2018cited by this paper
• Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

  2018cited by this paper
• Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia

  2017cited by this paper
• Triple Negative Breast Cancer: A Review

  2017cited by this paper
• The BRCA2 variant c.68-7 T>A is associated with breast cancer

  2017cited by this paper
• Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18

  2017cited by this paper
• Splicing and transcription touch base: co-transcriptional spliceosome assembly and function

  2017cited by this paper
• Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA

  2016cited by this paper
• Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance

  2016cited by this paper
• Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples

  2016cited by this paper
• TP53 mutations in epithelial ovarian cancer.

  2016influential reference
• Inherited Mutations in Women With Ovarian Carcinoma.

  2016cited by this paper
• Evaluation of Existing Methods for Human Blood mRNA Isolation and Analysis for Large Studies

  2016cited by this paper
• Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort

  2016cited by this paper
• Gene-panel sequencing and the prediction of breast-cancer risk.

  2015cited by this paper
• CtIP: A DNA damage response protein at the intersection of DNA metabolism.

  2015cited by this paper
• Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

  2015cited by this paper
• Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing

  2015cited by this paper
• The Fanconi Anemia Pathway Protects Genome Integrity from R-loops

  2015cited by this paper
• Functional characterization of BRCA1 gene variants by mini-gene splicing assay

  2014cited by this paper
• Comparison of Whole Blood RNA Preservation Tubes and Novel Generation RNA Extraction Kits for Analysis of mRNA and MiRNA Profiles

  2014cited by this paper
• Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia

  2014cited by this paper
• Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

  2014cited by this paper
• Breast cancer proteins PALB2 and BRCA2 stimulate polymerase η in recombination-associated DNA synthesis at blocked replication forks.

  2014cited by this paper
• Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis

  2014cited by this paper
• The role of BRCA1 in DNA double-strand repair: past and present.

  2013cited by this paper
• Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

  2013cited by this paper
• Identification of a non-canonical nuclear localization signal (NLS) in BRCA1 that could mediate nuclear localization of splice variants lacking the classical NLS

  2013influential reference
• Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood.

  2013cited by this paper
• The Interaction of CtIP and Nbs1 Connects CDK and ATM to Regulate HR–Mediated Double-Strand Break Repair

  2013cited by this paper
• Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities.

  2013cited by this paper
• PALB2 self-interaction controls homologous recombination

  2012cited by this paper
• BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

  2012cited by this paper
• Rad51 Paralog Complexes BCDX2 and CX3 Act at Different Stages in the BRCA1-BRCA2-Dependent Homologous Recombination Pathway

  2012cited by this paper
• Peripheral blood gene expression: it all boils down to the RNA collection tubes

  2012cited by this paper
• Human blood RNA stabilization in samples collected and transported for a large biobank

  2012cited by this paper
• A guide for functional analysis of BRCA1 variants of uncertain significance

  2012cited by this paper
• Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants

  2012cited by this paper
• Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members

  2011cited by this paper
• Mutagenicity associated with O6-methylguanine-DNA damage and mechanism of nucleotide flipping by AGT during repair

  2011cited by this paper
• An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition

  2011cited by this paper
• ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair

  2011cited by this paper
• Germline mutations in RAD51D confer susceptibility to ovarian cancer

  2011cited by this paper
• Mutation of the RAD51C gene in a Fanconi anemia–like disorder

  2010cited by this paper
• A High Proportion of DNA Variants of BRCA1 and BRCA2 Is Associated with Aberrant Splicing in Breast/Ovarian Cancer Patients

  2010cited by this paper
• An MLH1 Mutation Links BACH1/FANCJ to Colon Cancer, Signaling, and Insight toward Directed Therapy

  2010cited by this paper
• Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.

  2010cited by this paper
• Assembly and function of DNA double-strand break repair foci in mammalian cells.

  2010cited by this paper
• PALB2/FANCN: recombining cancer and Fanconi anemia.

  2010cited by this paper
• Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

  2010cited by this paper
• BRCA1 and its toolbox for the maintenance of genome integrity

  2010cited by this paper
• Structural basis for recruitment of BRCA2 by PALB2

  2009cited by this paper
• PALB2 is an integral component of the BRCA complex required for homologous recombination repair

  2009cited by this paper
• Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice‐site prediction programs

  2009cited by this paper
• A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer

  2009cited by this paper
• Mechanisms and functions of DNA mismatch repair

  2008cited by this paper
• Ataxia-telangiectasia and other Primary Immunodeficiency Diseases

  2008cited by this paper
• Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation

  2008cited by this paper
• Human CtIP promotes DNA end resection

  2007cited by this paper
• Extensive gene conversion at the PMS2 DNA mismatch repair locus

  2007cited by this paper
• Structure of the human MutSalpha DNA lesion recognition complex.

  2007cited by this paper
• Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

  2006cited by this paper
• Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links

  2006cited by this paper
• [Breast cancer].

  2006cited by this paper
• The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon

  2006cited by this paper
• Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking

  2005cited by this paper
• The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J

  2005cited by this paper
• The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia‐telangiectasia patients and their parents

  2004cited by this paper
• UniProt: the Universal Protein knowledgebase

  2004cited by this paper
• DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains

  2004cited by this paper
• Domain mapping of the Rad51 paralog protein complexes.

  2004cited by this paper
• How did alternative splicing evolve?

  2004cited by this paper
• Identification of BRCA1-IRIS, a BRCA1 locus product

  2004cited by this paper
• Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

  2004cited by this paper
• BRCA1 and BRCA2: 1994 and beyond

  2004cited by this paper
• The BRCT Domain Is a Phospho-Protein Binding Domain

  2003cited by this paper
• Homologous Recombination and Its Role in Carcinogenesis

  2002cited by this paper
• Insights into DNA recombination from the structure of a RAD51–BRCA2 complex

  2002cited by this paper
• BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

  2001cited by this paper
• Nuclear localization signals of the BRCA2 protein.

  2000cited by this paper
• [The Lynch syndrome].

  1999cited by this paper
• The Interaction of the Human MutL Homologues in Hereditary Nonpolyposis Colon Cancer*

  1999cited by this paper
• Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.

  1999cited by this paper
• Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations.

  1998cited by this paper
• The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor*

  1996cited by this paper
• Hereditary predisposition to breast cancer.

  1996cited by this paper

• No citing papers are available for this paper.